SBRT in HCC With Oligoprogression on First-line Immunotherapy
SBRT in HCC With Oligoprogression on First-line Immunotherapy
Recruiting · NCT06434480 · Registry updated 2026-05-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SBRT in HCC With Oligoprogression on First-line Immunotherapy | hepatocellular carcinoma | Recruiting | Not applicable | 2026-05-18 | NCT06434480 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chinese University of Hong Kong | 480 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Clinical Oncology, Prince of Wales Hospital | Hong Kong | Hong Kong | 16 |